The Impact of Yoga on Endometriosis-Related Pain

ConditionEndometriosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorMilton S. Hershey Medical Center

About this trial

The central hypothesis of the investigators is that the practice of yoga will result in an improvement of endometriosis related pain symptoms for women with endometriosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Reproductive aged women 18-45

Self-reported prior surgery with pathology confirming a diagnosis of endometriosis

No current use of yoga

Baseline moderate pain, score greater than or equal to 5 on VAS scoring

Disqualifiers

Pregnant patients

Established yoga participation or moderate exercise regimen

Physical trauma or disability

Planned surgery or hormonal medication change during study

Trial design

Design model

Single group

Treatments tested in this trial

  • Yoga

    Behavioral

    Participants will engage in a 12-week virtual yoga course to assess impact on endometriosis-related pain

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Yoga InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Endometriosis Health Profile-30 Pain Score

Identify the impact of yoga on endometriosis related pain based on the Endometriosis Health Profile-30, with specific focus on the domain of pain. The EHP-30 questionnaire consists of five scales which includes pain, control and powerlessness, emotional well-being, social support, and self-image and a total of 30 questions. Each scale is translated into a score ranging from 0, or the best health status, to 100, the worst health status.

Time frame
Baseline to completion at 12-weeks

Secondary outcomes

1

Change in Visual Analog Scale scores

Comparison of visual analog scale scores from start to the end of the study. The visual analog scale is a validated scale for measuring acute and chronic pain. Scores are recorded on a scale between 0 or "no pain" and 10, the "worst pain".

Time frame
Baseline to completion at 12-weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.